Independent & Data-Driven
The nervous system of the biotech industry.
We aggregate market trends, verify technical data, and build robust laboratory tools. Navigating the intersection of biological science and global commerce without the noise.
Market Trajectory
Venture funding and public market capitalization across key biotech sectors (2019–2024).
Deep dives into the sub-sectors reshaping medicine and agriculture.
CRISPR & Gene Editing
From Cas9 to prime editing, tracking the clinical pipeline and IP landscape of genomic medicine.
Read the guideAdvanced Diagnostics
Next-generation sequencing (NGS), liquid biopsies, and point-of-care infectious disease tracking.
Explore diagnosticsCDMO & Manufacturing
The backbone of biotech. Analyzing scale-up challenges, bioreactor capacity, and supply chains.
View landscapeBench tools you can trust.
We grew tired of ad-filled, broken calculators. Our suite of 15+ laboratory tools is fast, precise, and works entirely offline with zero tracking.
View all 15 toolsMolarity Calculator
Calculate mass, volume, or concentration for chemical solutions.
PCR Annealing Temp
Determine optimal Ta based on primer sequence and salt concentration.
Doubling Time
Track exponential growth phases in mammalian cell cultures.
RPM to RCF
Convert relative centrifugal force and revolutions per minute.
The Complete Company Directory
Profiles, clinical pipelines, and financial data for over 500 active biotechnology firms.
Career Paths & Compensation
We analyze thousands of H1B disclosures and user-submitted data points to provide an accurate picture of biotech salaries across major hubs like Boston, SF, and San Diego.
View full salary report| Role | Median Base (Boston) |
|---|---|
| Research Associate I | $72,000 |
| Scientist I (PhD) | $125,000 |
| Principal Scientist | $165,000 |
| Director of R&D | $210,000 |
Speak the Language
From 'Adjuvant' to 'Zygote', our comprehensive glossary defines over 1,000 industry terms clearly and concisely.
Editorial
Why reproducibility is the biggest threat to early-stage ventures.
It is estimated that over 50% of preclinical research is not reproducible, costing the industry approximately $28 billion annually in the US alone. We explore how stringent documentation, better reagent validation, and open-source bench tools are beginning to turn the tide.
Read the full essayGet the Weekly Digest
Join 15,000+ researchers and executives receiving our unvarnished analysis of FDA decisions, funding rounds, and clinical trial results every Tuesday.
We never sell your data. Unsubscribe at any time.
Our Methodology
Primary Sources Only
We rely exclusively on SEC filings, clinicaltrials.gov, and peer-reviewed journals. No secondary interpretations.
Independent Verification
Our tool algorithms are verified against standard laboratory textbooks (e.g., Sambrook's Molecular Cloning).
Zero Tracking
Your searches and tool usage remain entirely on your device. We use no marketing cookies.